National Institute on Aging; Notice of Closed Meeting, 48490-48491 [2022-16988]

Download as PDF 48490 Federal Register / Vol. 87, No. 152 / Tuesday, August 9, 2022 / Notices may have already undergone eSTAR set up for other types of submission, e.g., premarket notification, fewer respondents may need to undergo eSTAR setup than estimated. FDA estimates the burden of this collection of information as follows: TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1 Number of respondents Activity Number of responses per respondent Total annual responses Average burden per response Total hours ‘‘Requests for Feedback and Meetings for Medical Device Submissions: The Q-Submission Program’’ Q-Submissions: CDRH ............................................................... CBER ............................................................... 2,160 60 1 1 2,160 60 137 ..................... 137 ..................... 295,920 8,220 Q-Submissions Using eSTAR (21 CFR Part 814, Subparts A Through E; Section 745A(b) of the FD&C Act) CDRH ...................................................................... CBER ...................................................................... eSTAR setup ........................................................... Manufacturer request to participate in EPFP ......... 1,440 40 1,480 30 1 1 1 1 1,440 40 1,480 30 69 ....................... 69 ....................... 0.08 (5 minutes) 2 ......................... 99,360 2,760 118 60 Total .......................................................... ........................ ........................ ........................ ............................ 406,438 1 There are no capital costs or operating and maintenance costs associated with this collection of information. Including the EPFP form represents a revision to this information collection request. Our estimated burden for the information collection reflects the availability of eSTAR to assist electronic preparation of Q-submissions and addition of the EPFP form, resulting in an overall decrease of 85,803 hours. Dated: August 2, 2022. Lauren K. Roth, Associate Commissioner for Policy. [FR Doc. 2022–17058 Filed 8–8–22; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Biodefense Science Board Public Meeting Office of the Assistant Secretary for Preparedness and Response (ASPR), Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: The National Biodefense Science Board (NBSB or the Board), authorized under Section 319M of the Public Health Service (PHS) Act, as added by Section 402 of the Pandemic and All-Hazards Preparedness Act of 2006 and amended by Section 404 of the Pandemic and All-Hazards Preparedness Reauthorization Act, will hold a public meeting. The NBSB provides expert advice and guidance to the Department of Health and Human Services (HHS) regarding current and future chemical, biological, radiological, and nuclear threats, as well as other matters related to disaster preparedness and response. The Assistant Secretary jspears on DSK121TN23PROD with NOTICES SUMMARY: VerDate Sep<11>2014 18:04 Aug 08, 2022 Jkt 256001 for Preparedness and Response (ASPR) manages and convenes the NBSB on behalf the Secretary. A detailed agenda and Zoom registration instructions will be posted on the ASPR website at least two weeks in advance. DATES: The public meeting will be held on September 29, 2022 beginning at 11 a.m. Eastern time. FOR FURTHER INFORMATION CONTACT: CAPT Christopher Perdue, NBSB Designated Federal Official, NBSB@ hhs.gov, 202–401–5837. SUPPLEMENTARY INFORMATION: Those interested may attend the meeting via a toll-free phone number or Zoom teleconference, which requires preregistration. The meeting link to preregister will be posted on the meeting website. The online meeting will include American Sign Language interpretation and live captioning. Members of the public may provide written comments or submit questions at any time via email to NBSB@hhs.gov. Additionally, the NBSB invites stakeholders to request up to seven minutes to address the Board in-person during the meeting. The Board wishes to hear from experts from relevant biomedical, biodefense, or health industries; faculty or researchers at academic institutions; health professionals, health system experts, or those who work in health care consumer organizations; or experts in state, Tribal, territorial, or local government agencies. Requests to provide remarks to the NBSB during the public meeting must be sent to NBSB@hhs.gov by September 15, 2022. In that request, please provide the speaker’s name, title, position, and organization with a brief description of PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 the topic that they will address. Requests to speak to the Board will be approved in consultation with the Board Chair and based on time available during the meeting. Obvious commercial bias, to include any form of advertising, marketing, or solicitation, will not be allowed. Dawn O’Connell, Assistant Secretary for Preparedness and Response. [FR Doc. 2022–16978 Filed 8–8–22; 8:45 am] BILLING CODE 4150–37–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Aging; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Aging Special Emphasis Panel SARS–CoV–2 infection and genetic variations effects on Risk of Cognitive Decline. E:\FR\FM\09AUN1.SGM 09AUN1 Federal Register / Vol. 87, No. 152 / Tuesday, August 9, 2022 / Notices Date: September 9, 2022. Time: 12:00 p.m. to 3:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institute on Aging, Gateway Building, 7201 Wisconsin Avenue, Bethesda, MD 20892 (Virtual Meeting). Contact Person: RAJASRI ROY, Ph.D., Scientific Review Officer, Scientific Review Branch, National Institute on Aging, National Institutes of Health, Gateway Building 2W200, 7201 Wisconsin Avenue, Bethesda, MD 20892, (301) 496–6477, rajasri.roy@ nih.gov. Information is also available on the Institute’s/Center’s home page: www.nia.nih.gov/, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging Research, National Institutes of Health, HHS) Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2022–16988 Filed 8–8–22; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health jspears on DSK121TN23PROD with NOTICES National Cancer Institute; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Cancer Advisory Board. The meeting will be held as a virtual meeting and is open to the public as indicated below. Individuals who plan to view the virtual meeting and need special assistance or other reasonable accommodations to view the meeting should notify the Contact Person listed below in advance of the meeting. The meeting will be videocast and can be accessed from the NIH Videocasting and Podcasting website (https:// videocast.nih.gov/). A portion of the National Cancer Advisory Board meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Advisory Board. Date: August 31, 2022. VerDate Sep<11>2014 18:04 Aug 08, 2022 Jkt 256001 Open: 11:00 a.m. to 1:10 p.m. Agenda: NCAB Subcommittee Meetings— Ad Hoc Subcommittee on Experimental Therapeutics and Subcommittee on Planning and Budget. Open: 1:15 p.m. to 4:00 p.m. Agenda: Acting Director’s and Program reports and presentations; business of the Board. Closed: 4:10 p.m. to 5:30 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute—Shady Grove, 9609 Medical Center Drive, Rockville, MD 20850 (Virtual Meeting). Contact Person: Paulette S. Gray, Ph.D., Director, Division of Extramural Activities, National Cancer Institute—Shady Grove, National Institutes of Health, 9609 Medical Center Drive, 7th Floor, Room 7W444, Bethesda, MD 20892, 240–276–6340, grayp@ mail.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Information is also available on the Institute’s/Center’s home page: NCAB: https://deainfo.nci.nih.gov/advisory/ncab/ ncabmeetings.htm, where an agenda and any additional information for the meetings will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: August 4, 2022. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2022–17036 Filed 8–8–22; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Environmental Health Sciences; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Advisory Environmental Health Sciences Council. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend as well as those who need special assistance, such as sign language interpretation or other reasonable accommodations, PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 48491 should notify the Contact Person listed below in advance of the meeting. The open session will be videocast and can be accessed from the NIH Videocasting website (https://videocast.nih.gov/). The meeting will be closed to the public in accordance with the provisions set forth in section 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Advisory Environmental Health Sciences Council. Date: September 13–14, 2022. Closed: September 13, 2022, 10:00 a.m. to 10:45 a.m. Agenda: To review and evaluate grant applications. Place: Division of Extramural Research and Training, National Institute of Environmental Health Sciences, Durham, NC 27709 (Virtual Meeting). Open: September 13, 2022, 11:00 a.m. to 4:30 p.m. Agenda: Discussion of program policies and issues/Council Discussion. Place: Division of Extramural Research and Training, National Institute of Environmental Health Sciences, Durham, NC 27709, https:// www.niehs.nih.gov/news/webcasts/ (Virtual Meeting). Open: September 14, 2022, 10:00 a.m. to 1:00 p.m. Agenda: Discussion of program policies and issues/Council Discussion. Place: Division of Extramural Research and Training, National Institute of Environmental Health Sciences, Durham, NC 27709, https:// www.niehs.nih.gov/news/webcasts/ (Virtual Meeting). Contact Person: David M Balshaw, Ph.D., Acting Director and Chief, Division of Extramural Research and Training, National Institute of Environmental Health Sciences, P.O. Box 12233, MD EC–27, Research Triangle Park, NC 27709–2233, 984–287– 3234, balshaw@niehs.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Information is also available on the Institute’s/Center’s home page: https:// www.niehs.nih.gov/about/boards/naehsc/ agenda/index.cfm, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.115, Biometry and Risk Estimation—Health Risks from Environmental Exposures; 93.142, NIEHS Hazardous Waste Worker Health and Safety Training; 93.143, NIEHS Superfund E:\FR\FM\09AUN1.SGM 09AUN1

Agencies

[Federal Register Volume 87, Number 152 (Tuesday, August 9, 2022)]
[Notices]
[Pages 48490-48491]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-16988]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Aging; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Aging Special Emphasis 
Panel SARS-CoV-2 infection and genetic variations effects on Risk of 
Cognitive Decline.

[[Page 48491]]

    Date: September 9, 2022.
    Time: 12:00 p.m. to 3:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute on Aging, Gateway Building, 7201 
Wisconsin Avenue, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: RAJASRI ROY, Ph.D., Scientific Review Officer, 
Scientific Review Branch, National Institute on Aging, National 
Institutes of Health, Gateway Building 2W200, 7201 Wisconsin Avenue, 
Bethesda, MD 20892, (301) 496-6477, [email protected].

    Information is also available on the Institute's/Center's home 
page: www.nia.nih.gov/, where an agenda and any additional 
information for the meeting will be posted when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging 
Research, National Institutes of Health, HHS)

Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-16988 Filed 8-8-22; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.